Biofilm Formation and Virulence Determinants of Klebsiella oxytoca Clinical Isolates from Patients with Colorectal Cancer

J Gastrointest Cancer. 2020 Sep;51(3):855-860. doi: 10.1007/s12029-019-00317-7.

Abstract

Objective: Biofilm formation has made the therapy of bacterial infections more difficult. The objective our study was assessment of pan-drug-resistant (PDR) Klebsiella oxytoca pathogenicity and virulence factors causing AAHC in patients with colorectal cancer (CRC).

Materials and methods: Among a total of 300 healthy and 300 patients with antibiotic-associated hemorrhagic colitis (AAHC) and CRC, 200 K. oxytoca were identified during May 2015-January 2019. The virulence properties and biofilm formation among the isolates were investigated by phenotypic, PCR, and real-time PCR (RT-qPCR) techniques.

Results: The blaCTX-M1 (20%), blaSHV (11%), blaTEM1 (33%), and AmpC encoding CIT (2%) ESBL genes, carbapenemase-encoding genes blaIM (4%) and blaOXA-48 (2%), and colistin-resistant mcr-1 gene (2.5%) were detected. The virulence-encoding genes including fimA (80%), pilQ (100%), matB (100%), mrkA (80%), and npsB (100%) were amplified. Therefore, PDR K. oxytoca containing adhesins and toxin-encoding genes with ability of biofilm formation causing AAHC and CRC were isolated. There was a significant difference between healthy and patients with CRC regarding the presence of K. oxytoca (p = 00.221).

Conclusion: Bacterial enteric pathogens possibly play a role in CRC. Biofilm formation by K. oxytoca strains prevents the efficient infection elimination; therefore, rapid identification and control measure are chief requirements. Additionally, more investigations are necessary with this regard.

Keywords: Biofilm formation; Colorectal cancer; Drug resistance; Klebsiella oxytoca.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Biofilms / drug effects
  • Case-Control Studies
  • Colitis / chemically induced
  • Colitis / microbiology*
  • Colorectal Neoplasms / microbiology*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Genes, Bacterial / genetics
  • Healthy Volunteers
  • Hep G2 Cells
  • Humans
  • Klebsiella oxytoca / drug effects
  • Klebsiella oxytoca / genetics
  • Klebsiella oxytoca / isolation & purification
  • Klebsiella oxytoca / pathogenicity*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Virulence / genetics
  • Virulence Factors / genetics
  • Virulence Factors / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Virulence Factors